Floquet control uses time-periodic drives to engineer quantum systems, creating dynamic changes in material properties ...
The FDA granted fast track designation for CTx001, an investigational gene therapy candidate for geographic atrophy secondary ...
Many projects on these pages do clever things with video. Whether it’s digital or analogue, it’s certain our community can ...
Terahertz (THz) radiation, which occupies the frequency band between microwaves and infrared light, is essential in many next ...
Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today ...
Positive interim efficacy data in 2025 underscore potential of ETX101 as a one-time, disease-modifying medicine for Dravet syndrome –– Internal GMP manufacturing capable of supporting pivotal trial ...
Researchers at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) have uncovered previously unobserved oscillation ...
BHPian BlackBeard recently shared this with other enthusiasts:Hello folks. Since many enthusiasts here are keen on knowing ...
Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using Biohaven's proprietary MoDE and next-generation, highly selective ...
Bright Minds Biosciences (DRUG) stays a Strong Buy after Phase 2 BMB-101 seizure-reduction data; see 2026 catalysts, ...